ViewMind's news and publications

From recent awards, new partnerships, and scientific publications to press releases and new content about the future of diagnostics and monitoring of neurocognitive disorders

ViewMind Inc. were honored today to keynote at the in person Health 2.0 Conference on the topic of 'Digital Biomarkers for Evidence Based Management of Neurodegenerative Disorders' and to be recognized with 'Health 2.0 - Best Companies Award'

ViewMind is honored to have been selected in partnership with the Luxembourg Institute of Health to be the recipients of a 1.36 million euro grant awarded by the Luxembourg Ministry of the Economy, the Luxembourg National Research Fund (FNR), and Luxinnovation.

The project aims to clinically validate ViewMind’s technology to study neurocognitive deficiencies in Long COVID patients.

ViewMind Inc.'s CEO, Mark Edwards, is interviewed by the Silicon Review.

ViewMind Inc.’s CEO, Mark Edwards, is interviewed by the Silicon Review.

R3i Ventures, provider of successful start-ups

ViewMind Inc. is honored to be recognized by Business Worldwide in their '20 Most Innovative Companies to Watch Awards 2021'

ViewMind announces developer agreement with HP to help revolutionise the diagnosis and treatment of cognitive disorders

ViewMind and HP strike deal over cognitive disorders screening

El uso de la tecnología para la detección temprana de enfermedades neurodegenerativas

Full award write up by Frost & Sullivan

To be updated on ViewMind news please click buttons

Follow @viewmind_